GleamWall
中文EN

BLCO Bausch & Lomb Corp

Ophthalmic Goods · NYSE · SEC CIK 1860742 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.9%
TTM net income YoY63.6%
TTM EPS YoY62.8%
Revenue 3-yr CAGR10.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin7.1%
Net margin-2.0%
FCF margin4.7%
EBITDA margin14.5%

Returns

ROE-1.7%
ROA-0.8%
ROIC (approx.)2.8%
Asset turnover0.39x

Leverage & solvency

Liabilities / assets53.4%
Debt / equity0.78x
Current ratio1.56x
Interest coverage1.00x

Cash quality & payout

Operating cash flow / net income-4.99x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$5.10B$4.79B
R&D expense$371.00M$343.00M
SG&A expense$2.23B$2.08B
Operating income$113.00M$162.00M
Interest expense$421.00M$399.00M
Pretax income-$317.00M-$234.00M
Income tax$35.00M$71.00M
Net income-$360.00M-$317.00M
EBITDA$534.00M$598.00M
EPS (basic)-1.02-0.90
EPS (diluted)-1.02-0.90
Weighted avg. shares (diluted)353.80M351.80M
Balance sheet
Cash & equivalents$383.00M$316.00M
Receivables$1.22B$1.03B
Inventory$976.00M$1.04B
Current assets$2.98B$2.79B
PP&E, net$1.76B$1.49B
Goodwill$4.76B$4.52B
Intangibles$3.28B$3.49B
Total assets$14.02B$13.47B
Current liabilities$1.92B$1.74B
Short-term debt$28.00M$40.00M
Long-term debt$5.02B$4.74B
Total debt$5.05B$4.78B
Total liabilities$7.50B$6.92B
Shareholders' equity$6.45B$6.47B
Net debt$4.67B$4.47B
Shares outstanding354.21M352.40M
Cash flow statement
Operating cash flow$283.00M$232.00M
Capital expenditure$349.00M$291.00M
Free cash flow-$66.00M-$59.00M
Investing cash flow-$455.00M-$412.00M
Financing cash flow$225.00M$178.00M
Depreciation & amortization$421.00M$436.00M
Stock-based compensation$149.00M$92.00M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.